<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38293444</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Visual analysis of hotspots and trends in long COVID research based on bibliometric.</ArticleTitle><Pagination><StartPage>e24053</StartPage><MedlinePgn>e24053</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e24053</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e24053</ELocationID><Abstract><AbstractText>After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a series of symptoms may persist for a long time, which is now called long COVID. It was found that long COVID can affect all patients with COVID-19. Therefore, long COVID has become a hot topic. In this study, we used the WOS database as a sample data source to conduct a bibliometric and visual analysis of 1765 long COVID articles over the past three years through VOSviewer and R package. The results show that countries/authors in Europe and The United States of America contribute most of the articles, and their cooperation is also the most active. Keyword co-occurrence identified four clusters, with important topics including the mechanism, clinical symptoms, epidemiological characteristics, and management/treatment of long COVID. Themes such as "cognitive impairment", "endothelial dysfunction", "diagnosis", and "biomarkers" are likely to be the focus of new attention in the coming period. In addition, we put forward the possible research opportunities on long COVID for researchers and practitioners to facilitate future research.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Zongqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Adolescent Gynecology, Shenzhen Children's Hospital, Shenzhen, Guangdong, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Facheng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lining</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yunxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Department, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bibliometric analysis</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Research trends</Keyword><Keyword MajorTopicYN="N">VOSviewer</Keyword><Keyword MajorTopicYN="N">Visual analysis</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Zongqiang Lai reports financial support was provided by Guangxi Administration of traditional Chinese Medicine.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38293444</ArticleId><ArticleId IdType="pmc">PMC10827472</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e24053</ArticleId><ArticleId IdType="pii">S2405-8440(24)00084-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T.R., Needham D.M., Seylanova N., Parr C., Chen J., et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Med. 2022;20(1):50. doi: 10.1186/s12916-021-02222-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.A., Rao A.S., Nelakanti S.R., Kujalowicz C., Shi T., Rodriguez T., et al. Systematic review of aptamer sequence reporting in the literature reveals widespread unexplained sequence alterations. Anal. Chem. 2022;94(22):7731&#x2013;7737. doi: 10.1021/acs.analchem.1c04407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c04407</ArticleId><ArticleId IdType="pmc">PMC9179646</ArticleId><ArticleId IdType="pubmed">35420426</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Moschopoulos C.D., Margalit I., Gkrania-Klotsas E., Landi F., Stahl J.P., et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect. 2022;28(7):955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020.; London: 2020. Clinical Guidelines. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., et al. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 Years &#x2014; United States, March 2020&#x2013;november 2021. MMWR Morb. Mortal. Wkly. Rep. 2022;71(21):713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4) doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho R.H.W., To Z.W.H., Yeung Z.W.C., Tso E.Y.K., Fung K.S.C., Chau S.K.Y., et al. COVID-19 viral load in the severity of and recovery from olfactory and gustatory dysfunction. Laryngoscope. 2020;130(11):2680&#x2013;2685. doi: 10.1002/lary.29056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29056</ArticleId><ArticleId IdType="pmc">PMC7436903</ArticleId><ArticleId IdType="pubmed">32794209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J., Myall K., Lam J.L., Mason T., Mukherjee B., West A., et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021;76(4):408&#x2013;411. doi: 10.1136/thoraxjnl-2020-215861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215861</ArticleId><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID includes breathing and reproductive problems and has a range of risk factors. Nat. Med. 2022;28(8):1554&#x2013;1555. doi: 10.1038/s41591-022-01954-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01954-5</ArticleId><ArticleId IdType="pmc">PMC9373893</ArticleId><ArticleId IdType="pubmed">35962207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller M.C., Liang C.J., Marques A.R., Chung J.Y., Shanbhag S.M., Fontana J.R., et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann. Intern. Med. 2022;175(7):969&#x2013;979. doi: 10.7326/m21-4905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re'em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman M.P., Rahman T., Bora K., Borgohain C. COVID-19 pandemic and its recovery time of patients in India: a pilot study. Diabetes Metabol. Syndr. 2020;14(5):1205&#x2013;1211. doi: 10.1016/j.dsx.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7343664</ArticleId><ArticleId IdType="pubmed">32673841</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleberg M., Niemann C.U., Moestrup K.S., Kirk O., Lebech A.M., Lane C., et al. Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy. J. Infect. Dis. 2020;222(7):1103&#x2013;1107. doi: 10.1093/infdis/jiaa446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa446</ArticleId><ArticleId IdType="pmc">PMC7454684</ArticleId><ArticleId IdType="pubmed">32702095</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L.Y., Yuan W.F., Ai W.B., Ai Y.W., Wang J.J., Chu L.Y., et al. An exploration of aptamer internalization mechanisms and their applications in drug delivery. Expet Opin. Drug Deliv. 2019;16(3):207&#x2013;218. doi: 10.1080/17425247.2019.1575808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17425247.2019.1575808</ArticleId><ArticleId IdType="pubmed">30691313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr P., Scharnhorst A. Scientometrics and information retrieval - weak-links revitalized. Scientometrics. 2014;102(3):2193&#x2013;2199. doi: 10.1007/s11192-014-1484-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-014-1484-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y., Zhu R., Maimaituerxun M. Bibliometric review of carbon neutrality with CiteSpace: evolution, trends, and framework. Environ. Sci. Pollut. Res. Int. 2022;29(51):76668&#x2013;76686. doi: 10.1007/s11356-022-23283-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-23283-3</ArticleId><ArticleId IdType="pubmed">36169840</ArticleId></ArticleIdList></Reference><Reference><Citation>Priovashini C., Mallick B. A bibliometric review on the drivers of environmental migration. Ambio. 2022;51(1):241&#x2013;252. doi: 10.1007/s13280-021-01543-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13280-021-01543-9</ArticleId><ArticleId IdType="pmc">PMC8651838</ArticleId><ArticleId IdType="pubmed">33738730</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M., Xu S., Weng J. A bibliometric study of COVID-19 research in Web of Science. Pharmacol. Res. 2021;169 doi: 10.1016/j.phrs.2021.105664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105664</ArticleId><ArticleId IdType="pmc">PMC8106965</ArticleId><ArticleId IdType="pubmed">33979689</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Gao J., Kang J., Wang X., Niu Q., Liu J., et al. Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002-2021) Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.939433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939433</ArticleId><ArticleId IdType="pmc">PMC9353180</ArticleId><ArticleId IdType="pubmed">35935932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai H., Yang M., Sun M., Pan B., Wang Q., Wang J., et al. Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism. 2022;137 doi: 10.1016/j.metabol.2022.155330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2022.155330</ArticleId><ArticleId IdType="pmc">PMC9546784</ArticleId><ArticleId IdType="pubmed">36220361</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatr. 2021;8(2):130&#x2013;140. doi: 10.1016/s2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.M., Yan W., Li C., Lu Q.D., Liu L., et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol. Psychiatr. 2023;28(1):423&#x2013;433. doi: 10.1038/s41380-022-01614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., Ladhani S.N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 2022;35(5):461&#x2013;467. doi: 10.1097/qco.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qco.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Dao T.L., Dudouet P., Eldin C., Gautret P. Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41(4):515&#x2013;545. doi: 10.1007/s10096-022-04417-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-022-04417-4</ArticleId><ArticleId IdType="pmc">PMC8830952</ArticleId><ArticleId IdType="pubmed">35142947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H., Lu L., Fan H. Global trends and research hotspots in long COVID: a bibliometric analysis. Int. J. Environ. Res. Publ. Health. 2022;19(6):3742. doi: 10.3390/ijerph19063742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063742</ArticleId><ArticleId IdType="pmc">PMC8955790</ArticleId><ArticleId IdType="pubmed">35329428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.H., Jeon S.R., Kang J.W., Kwon S. Complementary and alternative medicine for long COVID: scoping review and bibliometric analysis. Evid Based Complement Alternat Med. 2022:7303393&#x2013;7303400. doi: 10.1155/2022/7303393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7303393</ArticleId><ArticleId IdType="pmc">PMC9371860</ArticleId><ArticleId IdType="pubmed">35966751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Yang Z. Knowledge mapping of platform research: a visual analysis using VOSviewer and CiteSpace. Electron. Commer. Res. 2020;22(3):787&#x2013;809. doi: 10.1007/s10660-020-09410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10660-020-09410-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Aria M., bibliometrix C. Cuccurullo. An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959&#x2013;975. doi: 10.1016/j.joi.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2017.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.K., Neylon C., Hosking R., Montgomery L., Wilson K.S., Ozaygen A., et al. Evaluating the impact of open access policies on research institutions. Elife. 2020;9 doi: 10.7554/eLife.57067.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57067</ArticleId><ArticleId IdType="pmc">PMC7536542</ArticleId><ArticleId IdType="pubmed">32924933</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Muller S., Kanduc D., David P., Halpert G., Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun. Rev. 2021;20(4) doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Maple P.A.C. COVID-19, SARS-CoV-2 vaccination, and human herpesviruses infections. Vaccines (Basel). 2023;11(2) doi: 10.3390/vaccines11020232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020232</ArticleId><ArticleId IdType="pmc">PMC9963083</ArticleId><ArticleId IdType="pubmed">36851110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang J., Wang H., Xue X., Zhang S. Microbiota and COVID-19: long-term and complex influencing factors. Front. Microbiol. 2022;13 doi: 10.3389/fmicb.2022.963488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.963488</ArticleId><ArticleId IdType="pmc">PMC9417543</ArticleId><ArticleId IdType="pubmed">36033885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3) doi: 10.1053/j.gastro.2020.05.048. 944-955.e948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Bradley E., Zeamer A.L., Cincotta L., Salive M.C., Dutta P., et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 2021;6(20) doi: 10.1172/jci.insight.152346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36(6) doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V., Izzo R., Zanforlin A., Tursi F., Scarpelli F., Santus P., et al. Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN Study. Pharmacol. Res. 2022;185 doi: 10.1016/j.phrs.2022.106486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106486</ArticleId><ArticleId IdType="pmc">PMC9531936</ArticleId><ArticleId IdType="pubmed">36206959</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28(11):2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann. Intern. Med. 2021;174(9):1252&#x2013;1260. doi: 10.7326/m21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 2021;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C.J. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur. Respir. J. 2020;56(5) doi: 10.1183/13993003.03276-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27(1):89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534. doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G., Newcomb R., Cowl C.T., Murad M.H., Breeher L., Miller S., et al. Post-COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort. Mayo Clin. Proc. 2021;96(7):1782&#x2013;1791. doi: 10.1016/j.mayocp.2021.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9) doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N.G., Abbott S., Barnard R.C., Jarvis C.I., Kucharski A.J., Munday J.D., et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538) doi: 10.1126/science.abg3055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg3055</ArticleId><ArticleId IdType="pmc">PMC8128288</ArticleId><ArticleId IdType="pubmed">33658326</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J. Clin. Med. 2022;11(24) doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9(2):129. doi: 10.1016/s2213-2600(21)00031-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(21)00031-x</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.E., Kim T., Yun K.W., Lee S.H., Lee E., et al. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect Chemother. 2022;54(3):566&#x2013;597. doi: 10.3947/ic.2022.0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2022.0141</ArticleId><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R., Trimarco V., Mone P., Alo&#xe8; T., Capra Marzani M., Diana A., et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: the LINCOLN Survey. Pharmacol. Res. 2022;183 doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry M.A., Berg R.M.G., Shelley J., Hudson J., Saynor Z.L., Duckers J., et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur. Respir. J. 2022;60(4) doi: 10.1183/13993003.03101-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Seethamraju H., Dhody K., Corley M.J., Kazempour K., Lalezari J., et al. CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int. J. Infect. Dis. 2021;103:25&#x2013;32. doi: 10.1016/j.ijid.2020.10.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.101</ArticleId><ArticleId IdType="pmc">PMC7654230</ArticleId><ArticleId IdType="pubmed">33186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268 doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27(1):28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3) doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., et al. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6(9) doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110(3):914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Inf. Disp. 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12 doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D., Savale L., Noel N., Meyrignac O., Colle R., Gasnier M., et al. Post-acute COVID-19 syndrome. Eur. Respir. Rev. 2022;31(163) doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin. Med. 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22(4):e102&#x2013;e107. doi: 10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir. Med. 2022;10(9):863&#x2013;876. doi: 10.1016/s2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., et al. Trajectory of long covid symptoms after covid-19 vaccination: community-based cohort study. BMJ. 2022;377 doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Group P.-C.C. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 2022;10(8):761&#x2013;775. doi: 10.1016/s2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 2022;182(1):19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., de Stavola B.L., Rojas N., McOwat K., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc. 2022;6(4):230&#x2013;239. doi: 10.1016/s2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., Zhang A.X.D., O'Mahoney L.L., Stephenson T.J., et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84(2):158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., Bundgaard H., Palm P., Rotvig C., et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (Long COVID Kids DK): a national, cross-sectional study. Lancet Child Adolesc. 2022;6(4):240&#x2013;248. doi: 10.1016/s2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. doi: 10.1016/s2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Jones D.M., Morris P.B., Ballantyne C.M., Birtcher K.K., Covington A.M., DePalma S.M., et al. ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of cardiology solution set oversight committee. J. Am. Coll. Cardiol. 2022;80(14):1366&#x2013;1418. doi: 10.1016/j.jacc.2022.07.006. 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.07.006</ArticleId><ArticleId IdType="pubmed">36031461</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield B.A., Bhatt D.L., Gersh B.J. Cardiac involvement in the long-term implications of COVID-19. Nat. Rev. Cardiol. 2022;19(5):332&#x2013;341. doi: 10.1038/s41569-021-00631-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00631-3</ArticleId><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir I., Lovik A., Unnarsd&#xf3;ttir A.B., McCartney D., Ask H., K&#xf5;iv K., et al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. Lancet Public Health. 2022;7(5):e406&#x2013;e416. doi: 10.1016/s2468-2667(22)00042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J., et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378 doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28(7):1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds C.J., Pade C., Gibbons J.M., Otter A.D., Lin K.M., Mu&#xf1;oz Sandoval D., et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science. 2022;377(6603) doi: 10.1126/science.abq1841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abq1841</ArticleId><ArticleId IdType="pmc">PMC9210451</ArticleId><ArticleId IdType="pubmed">35699621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo F., Abolhassani H., Du L., Piralla A., Bertoglio F., de Campos-Mata L., et al. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat. Commun. 2022;13(1):2670. doi: 10.1038/s41467-022-30340-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30340-5</ArticleId><ArticleId IdType="pmc">PMC9106736</ArticleId><ArticleId IdType="pubmed">35562366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Hilgenfeld R., Whitley R., De Clercq E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 2023;22(6):449&#x2013;475. doi: 10.1038/s41573-023-00672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-023-00672-y</ArticleId><ArticleId IdType="pmc">PMC10113999</ArticleId><ArticleId IdType="pubmed">37076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023;20(5):281&#x2013;282. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard S.A., Pollett S.D., Fries A.C., et al. Persistent COVID-19 symptoms at 6 Months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw. Open. 2023;6(1) doi: 10.1001/jamanetworkopen.2022.51360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.M., Munter S.E., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Invest. 2023;133(3) doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380 doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern. Med. 2023;183(6):554&#x2013;564. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61(1) doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H., Hanson A.L., Lodge S., et al. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat. Immunol. 2023;24(2):349&#x2013;358. doi: 10.1038/s41590-022-01380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner P.  In: For 7 Weeks I Have Been through a Roller Coaster of Ill Health, Extreme Emotions, and Utter Exhaustion. Garner Paul., editor. 2020. https://blogs.bmj.com/bmj/2020/05/05/paul-garner-people-who-have-a-more-protracted-illness-need-help-to-understand-and-cope-with-the-constantly-shifting-bizarre-symptoms/</Citation></Reference><Reference><Citation>The L. Long COVID: 3 years in. Lancet. 2023;401(10379):795. doi: 10.1016/s0140-6736(23)00493-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(23)00493-2</ArticleId><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH Plans Research on  &#x201c;Long COVID&#x201d;. 2023. https://covid19.nih.gov/news-and-stories/research-on-long-covid</Citation></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., et al. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 2023;108(1):12&#x2013;27. doi: 10.1113/ep090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/ep090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q., Lau R.I., Liu Q., Chan F.K.L., Ng S.C. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance. Gut. 2022 doi: 10.1136/gutjnl-2022-328319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-328319</ArticleId><ArticleId IdType="pubmed">35940857</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5) doi: 10.1016/j.cell.2022.01.014. 881-895.e820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022;608(7922):258&#x2013;260. doi: 10.1038/d41586-022-02140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Lee J.H., Kim J., Xiong F., Hasani L.A., Shi Y., et al. SARS-CoV-2 restructures host chromatin architecture. Nat Microbiol. 2023;8(4):679&#x2013;694. doi: 10.1038/s41564-023-01344-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01344-8</ArticleId><ArticleId IdType="pmc">PMC10116496</ArticleId><ArticleId IdType="pubmed">36959507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>